NUR 411 Module 4 Research Appraisal Example

Heavy Blanket, Light Blanket: A Critical Appraisal of a Randomized Trial of Weighted Chain Blankets for Insomnia

[Student Name]

Southern New Hampshire University

NUR 411: Understanding Research to Guide Nursing Practice

Module Four Assignment

[Instructor Name]

[Date]

The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.

Heavy Blanket, Light Blanket: A Critical Appraisal of a Randomized Trial of Weighted Chain Blankets for Insomnia

Module 3 ranked the randomized trial by Ekholm et al. (2020) as one of the two strongest sources for 3 North's question, a composite adult inpatient psychiatric unit considering weighted blankets at bedtime. A strong design, however, does not guarantee a trustworthy result. This appraisal is organized by the three questions in the Critical Appraisal Skills Programme checklist for randomized trials, about validity, about the findings themselves and about local usefulness (Critical Appraisal Skills Programme, n.d.), and then assigns a quality rating under the Johns Hopkins model (Dang et al., 2022). It concludes that the trial is well designed and reports a large effect on insomnia, but that its self-reported primary outcome, unblinded participants and outpatient setting mean the unit should expect a smaller and less certain benefit in its own patients. The appraisal is based on the published abstract and article details available to the student.

Are the Results Valid?

The trial addressed a clearly focused question: whether weighted chain blankets improve insomnia and related daytime symptoms in adults with one of four diagnoses: major depression, bipolar disorder, generalized anxiety or attention deficit hyperactivity disorder. Participants were randomized 1:1, which is the strongest protection against selection bias, and all 120 were patients with diagnosed psychiatric disorders rather than healthy volunteers. The comparison was an active control: a light plastic chain blanket rather than no blanket, which helps separate the effect of weight from the effect of simply receiving a new blanket and the attention that comes with it.

Blinding is the main weakness, and it is built into the question. Participants can feel the difference between a heavy blanket and a light one, so they could not be fully blinded to their group, and the primary outcome, the Insomnia Severity Index, is self-reported. Participants who expected a heavy blanket to help may have rated their sleep more favorably. The trial partly offsets this risk by also measuring sleep and daytime activity with wrist actigraphy, an objective measure less open to expectation. Readers should also check how many participants completed the four weeks and whether the analysis included everyone randomized, since dropouts in trials of sleep interventions can shift results.

What Are the Results?

At four weeks, the weighted blanket group had significantly better Insomnia Severity Index scores than the light blanket group, with a large effect size (Cohen's d = 1.90). The weighted blanket group also had better sleep maintenance, higher daytime activity and lower daytime fatigue, depression and anxiety. No serious adverse events occurred. In an open 12-month follow-up, participants who continued with weighted blankets maintained the improvement, and those who switched from the light to the weighted blanket improved by a similar amount (Ekholm et al., 2020).

An effect size near 2 is very large for a behavioral intervention, larger than most sleep medications show in trials. That size is encouraging, but it also calls for caution, because large effects in unblinded trials with self-reported outcomes can be inflated by expectation. The consistency of the objective actigraphy findings and the follow-up results supports the conclusion that the effect is real, even if its true size may be somewhat smaller. The 12-month phase was open label, so it adds information about persistence and tolerability rather than stronger proof of effect.

Will the Results Help Locally?

Applicability to 3 North is the weakest link. The trial enrolled outpatients who used the blankets at home for four weeks. 3 North's patients are acutely ill inpatients who stay about a week, sleep in an unfamiliar environment and may receive sedating medications. The trial's diagnoses overlap with the unit's population but do not include psychosis, which is common on 3 North. Outcomes that matter to the unit, such as night-time requests for as-needed medication, were not measured. On the other hand, the absence of serious adverse events in 120 patients is reassuring, and the blanket is inexpensive and easy to stop, which lowers the cost of trying it with appropriate safety criteria.

What to Check in the Full Article

Some questions an appraiser should answer cannot be settled from a summary. The full article should be read for the exact blanket weights and how participants were instructed to use them, the number of participants who withdrew in each group and whether the analysis included all randomized participants, how outcome assessors were managed, and who funded the trial and supplied the blankets. Commercial involvement does not invalidate a study, but it should be disclosed and considered. Recording these checks in the appraisal, and noting which were confirmed, keeps the rating honest.

Quality Rating

Under the Johns Hopkins model, the trial is Level I evidence. For quality, it earns a rating of B, good. It has a sufficient sample for its primary outcome, a randomized design with an active control, validated and objective measures and consistent results, which would support an A rating. The unavoidable lack of participant blinding on a self-reported primary outcome, together with a setting and duration different from the unit's, keeps it from the highest rating for this question. Dang et al. (2022) describe quality ratings as a judgment about how well a study was conducted and how consistent and generalizable its results are, which fits this assessment.

Implications for 3 North

The appraisal supports three conclusions for the unit. First, there is good evidence that weighted blankets can improve insomnia in adults with several psychiatric disorders, with no serious harms reported. Second, the size of the benefit for people in acute crisis during a stay of several nights is uncertain and probably smaller than the trial's effect. Third, any local use should include clear safety criteria and should measure outcomes the unit cares about, including sleep, anxiety, as-needed medication requests and adverse events, so that the unit learns whether the trial's promise holds in its own setting.

Conclusion

The weighted chain blanket trial is a well-designed randomized study with a large, consistent effect on insomnia and no serious adverse events. Its self-reported primary outcome with unblinded participants and its outpatient, four-week design limit how directly it answers 3 North's question. It is strong enough to justify a careful local trial, and not strong enough to justify expecting the same large effect on a busy acute unit.

References

Critical Appraisal Skills Programme. (n.d.). CASP randomised controlled trial checklist. https://casp-uk.net/casp-tools-checklists/randomised-controlled-trial-rct-checklist/

Dang, D., Dearholt, S. L., Bissett, K., Ascenzi, J., & Whalen, M. (2022). Johns Hopkins evidence-based practice for nurses and healthcare professionals: Model and guidelines (4th ed.). Sigma Theta Tau International.

Ekholm, B., Spulber, S., & Adler, M. (2020). A randomized controlled study of weighted chain blankets for insomnia in psychiatric disorders. Journal of Clinical Sleep Medicine, 16(9), 1567-1577. https://doi.org/10.5664/jcsm.8636